This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Medical Xpress - Cardiology
MARCH 25, 2024
Higher body mass index (BMI) variability is associated with adverse cardiovascular disease (CVD) events, according to a study published online March 21 in JAMA Network Open.
88 
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2025
BackgroundCurrent evidence suggests that cardiovascular disease (CVD) plays a role in the progression of chronic obstructive pulmonary disease (COPD). However, the relationship between CVD and the severity of COPD remains inadequately understood.
52 
Cardiovascular Diabetology
JULY 15, 2024
BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.
59 
Cardiovascular Diabetology
MARCH 25, 2025
Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.
59 
Dr. Paddy Barrett
DECEMBER 13, 2024
When it comes to cardiovascular disease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Excess weight, as measured by BMI, is typically considered a measure of excess body fat. Relationship of BMI and Risk Of Diabetes. But only moderately.
Frontiers in Cardiovascular Medicine
MARCH 14, 2025
BackgroundObesity is a global epidemic and a major risk factor for cardiovascular diseases. Laparoscopic sleeve gastrectomy (LSG) is an effective bariatric surgery, but its effect on cardiac functions remains unclear.
52 
Med Page Today
APRIL 10, 2025
(MedPage Today) -- Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body mass index (BMI), use of biologic drugs for RA, and, crucially, whether they carry anti-citrullinated.
65 
American College of Cardiology
JANUARY 10, 2025
Among patients without diabetes or cardiovascular disease and with a BMI 27 kg/m2, those with coronary artery calcium (CAC) scoring 300 derive the largest benefit from a weight-loss-dose of semaglutide for the prevention of major adverse cardiovascular events (MACE).
68 
Cardiovascular Diabetology
JANUARY 28, 2025
Triglyceride-glucose-BMI (TyG-BMI) index is a surrogate marker of insulin resistance and an important predictor of cardiovascular disease. However, the predictive value of TyG-BMI index in the progression of n.
52 
Cardiovascular Diabetology
MAY 8, 2024
The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovascular disease. However, the link between TyG-BM.
59 
Cardiovascular Diabetology
MAY 17, 2024
Insulin resistance (IR) significantly contributes to cardiovascular disease (CVD) development. Triglyceride glucose (TyG) index and triglyceride glucose-body mass index (TyG-BMI) are recognised as convenient p.
Dr. Paddy Barrett
APRIL 4, 2025
When it comes to a proper ‘explanation’ of cardiovascular disease or a ‘plan’ to address it, you will have to learn or address a lot of this on your own. Some doctors are less interested in cardiovascular disease; their particular interest may be in another area, e.g., migraines or gastrointestinal health.
Circulation
NOVEMBER 11, 2024
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The hemophilia cohort was slightly older (63.2[16.8]
40 
Frontiers in Cardiovascular Medicine
FEBRUARY 28, 2024
Background Cardiovascular diseases remain a leading cause of morbidity and mortality worldwide. Accurately predicting the 10-year risk of Atherosclerotic Cardiovascular Disease (ASCVD) is crucial for timely intervention and management. ratio (WHT.5R)—were 5R)—were calculated.
64 Journal of the American Heart Association
MARCH 26, 2025
as BMI increased by category, and it prevailed more frequently among women and older people regardless of their BMI status. kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). The incidence of SMuRFlessness declined from 16.2%
Physiologically Speaking
JANUARY 5, 2024
Exercise prevents and reverses cardiovascular disease, but whether high-intensity exercise training (HIIT) is safe and effective for adults after minimally invasive heart surgery is unknown. Exercise is a wonder drug for cardiovascular disease (CVD) prevention and reversal. VO2 peak increased by 3.3
119 
Open Heart
JUNE 9, 2023
Body mass index (BMI) ‘(weight (kg)/height (m) 2 ) was calculated and patients with BMI ≥30 kg/m 2 were categorised as obese. The mean BMI was 27.48±4.93 Methods In this observational study, we included patients presenting with STE-ACS undergoing primary percutaneous coronary intervention (PCI).
40 
Circulation
NOVEMBER 11, 2024
Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Compared to the control group, the GLP1RA cohort had a higher baseline risk profile (BMI: 35.1 [SD Hispanic, 9.6% Asian, and 4.6%
Stroke Journal
FEBRUARY 1, 2024
It is currently unknown if these associations are confounded by pleiotropic effects of the instrumental variables (IV) on cardiovascular disease (CVD) risk factors, such as low-density lipoprotein cholesterol (LDL), diastolic blood pressure (DBP), and body mass index (BMI). 0.96]), or BMI (TSAT: 1.18 [1.04-1.34];
40 
Frontiers in Cardiovascular Medicine
FEBRUARY 29, 2024
Background High pulse pressure (PP) and aortic root diameter (AoD) are hallmarks of arterial stiffness or vascular aging and they are considered as risk factors for age-related cardiovascular disease, including heart failure (HF). However, the relationship between PP and AoD in patients with heart failure (HF) is uncertain.
Cardiometabolic Health Congress
AUGUST 14, 2024
It also highlights the need for culturally adapted care recommendations, aligning with our earlier discussion on patient-centered approaches.
52 
Cardiometabolic Health Congress
JANUARY 3, 2024
For this reason, the practice guidelines for treating obesity recommend screening adults for overweight and obesity using BMI, diagnosing and establishing treatment targets based on their weight-related complications, as well as using pharmacotherapy and surgery for appropriate patients.
97 
European Journal of Heart Failure
NOVEMBER 19, 2024
BMI, body mass index; CV, cardiovascular; CVD, cardiovascular disease; HELLP, haemolysis, elevated liver enzymes, low platelet count. Abstract During pregnancy, the maternal cardiovascular (CV) system undergoes major haemodynamic alterations ensuring adequate placental perfusion and a healthy pregnancy course.
40 
DAIC
MAY 10, 2024
A, Normal axillary lymph nodes measuring milla1cf Fri, 05/10/2024 - 08:12 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovascular disease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN).
Circulation
NOVEMBER 11, 2024
Background:Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD) and is the leading cause of morbidity and mortality globally, with a rise in prevalence in low and middle-income countries (LMIC). Median BMI was 27.6 Circulation, Volume 150, Issue Suppl_1 , Page A4146960-A4146960, November 12, 2024.
40 
Hypertension Journal
OCTOBER 13, 2023
were hypertensives, and 8 factors, including diabetes, age ≥65 years, higher waist circumference, (BMI) ≥30 kg/m2, lack of formal education, living in urban residence, family history of cardiovascular diseases, and dyslipidemia use were associated with hypertension.
40 
European Journal of Heart Failure
DECEMBER 13, 2023
BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear.
40 
Stroke Journal
JANUARY 30, 2025
Background:Racial disparities have been well described in cardiovascular disease. Stroke, Volume 56, Issue Suppl_1 , Page AWP294-AWP294, February 1, 2025. Patients were categorized into two groups, one with Black or African American and another with White race patients. Both groups were followed for 12 months.
Stroke Journal
FEBRUARY 1, 2024
Participants with LVI were significantly older, male, Black, had higher BMI, and lower HDL. There was no significant difference in history of cardiovascular disease events (6% versus 4%, p=0.143). Participants with LVI were more likely to have diabetes, tobacco use, and atrial fibrillation (24% versus 14%, p<0.001).
Circulation
NOVEMBER 11, 2024
Introduction:Peak oxygen uptake (VO2peak), standardized to total body mass (ml/kg/min) is a predictor of morbidity and mortality in cardiovascular disease patients. years, BMI of 30.3±5.7, Circulation, Volume 150, Issue Suppl_1 , Page A4147807-A4147807, November 12, 2024. Improvement in VO2peak was defined as >% increase.
Dr. Paddy Barrett
OCTOBER 31, 2023
A healthy lifestyle, in this instance, is defined by a combination of: BMI Nutrition Smoking Status Activity Levels Blood Pressure Diabetes Status Cholesterol Levels All of which are highly modifiable. An elevated Lp(a) does increase the risk of early cardiovascular disease, but that risk is not set in stone. Atherosclerosis.
Physiologically Speaking
JANUARY 26, 2024
COSMOS tested a cocoa extract supplement and a multivitamin-mineral supplement against one another and a placebo for reducing the risk of cardiovascular disease and cancer. This hypothesis was studied in a randomized controlled trial known as the COcoa Supplement and Multivitamin Outcomes Study or COSMOS.
52 
Cardiology Update
JANUARY 24, 2024
The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.
Frontiers in Cardiovascular Medicine
DECEMBER 13, 2023
LH individuals also appear to have more cardiovascular disease (CVD) related conditions like diabetes and cancer. FMD was significantly ( p = 0.043) lower in LH (6.1% ± 3.2%) compared to RH (7.6% ± 3.8%), independent of age, sex, race, BMI, and HDL. Background Approximately 10% of the world is left-handed (LH).
DAIC
FEBRUARY 1, 2024
The HEART Study is the world's first clinical trial investigating the use of genomic 'polygenic risk score (PRS) testing' to support the prevention of cardiovascular disease ( CVD ) in National Health Service (NHS) clinical practice. Prevention is at the heart of what we do as GPs and risk assessment underpins that.
DAIC
JUNE 25, 2024
According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association , heart disease has been the leading cause of death in the U.S. It’s an honor to have the U.S.’s
Cardiometabolic Health Congress
JULY 25, 2023
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5
52 
Dr. Paddy Barrett
MAY 24, 2024
The greatest risk for a shortened life expectancy and early onset of diseases arises when you move from pre-diabetes to diabetes. A diagnosis of diabetes pulls forward the time you are likely to develop cardiovascular disease by a whopping ten years 6. All of these patients had a BMI >27. How To Reverse Diabetes.
110 
DAIC
APRIL 24, 2024
Among participants with baseline body mass index (BMI) above 30 kg/m2, 70.4% Eighty percent of heart attacks and strokes are preventable. Yet, CVD remains the leading cause of death in the U.S., reduced their weight within 3 months with a mean reduction of 8.8
116 
Physiologically Speaking
FEBRUARY 23, 2024
However, a series of recent studies in mice and in humans reveals that protein may promote a cascade of events in the body that lead to cardiovascular disease. All of this is true, yet some observational studies (with all of their inherent flaws) have associated a high (animal) protein intake with cardiovascular disease risk.
111 
European Journal of Heart Failure
DECEMBER 18, 2024
Association between body mass index (BMI) and clinical outcomes in PARADISE-MI. ( A ) Histogram for BMI (kg/m 2 ), ( B ) adverse events for BMI subgroups, and spline model curves for ( C ) the primary composite outcome and ( D ) cardiovascular (CV) death by BMI subgroups. 100 patient-years for BMI 40kg/m 2 ).
Heart BMJ
SEPTEMBER 16, 2024
In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013. 1 Obesity can adversely affect several health conditions but about two-thirds of deaths attributable to excess body mass index (BMI) are cardiovascular.
52 
Dr. Paddy Barrett
MARCH 23, 2024
They get the diseases of ageing about 20 to 25 years later than everyone else. It’s not that they don’t get cardiovascular disease, cancer or dementia; they just get it way later than everyone else. Most adults, healthy centenarians included, will die from one of three things: Cardiovascular Disease.
106 
Stroke Journal
FEBRUARY 1, 2024
Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Trends, demographics, comorbidities, and outcomes were then compared between the two cohorts.Results:Overall Prevalence of stroke was higher in the MHO-ve cohort (2.4%
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content